SBIR/STTR Research Award

Novel Metal Affinity Peptide and Protein Separations

Award identifier d76bd1c2ae1f26b9bdbe5f31514850670dd31104c6196ab5ee6238b9c029a250Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$89,984

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
IBC ADVANCED TECHNOLOGIES, INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
GLBQFN3DLH33
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION: (Applicant's abstract) The long-term objective is to use a novel separations technology to improve markedly the efficiency of peptide and protein separations and to extend these separations to a wide variety of peptides and proteins. The specific aim of the Phase I research is to test novel supported ligands for their ability to separate selectively tripeptides (capped and uncapped), each of which is composed of the same amino acid chosen from among those with side groups sulfhydryl (methionine, cysteine), protonated amine (lysine), carboxyl (aspartic acid, glutamic acid), and imidazole (histidine). Success in the Phase I and Phase II studies has the potential to make possible a rapid means for achieving highly selective separations of a wide variety ofpeptides and proteins. The research design involves the use in colunm form of available supported materials consisting of ligands chemically bonded to several supports to separate individual tripeptides from their mixtures with different tripeptides. Separations will be further enhanced by altering pH and eluent conditions. It is expected that separation factors of 10 to 100 will be achieved, making bind-release operations possible in many cases. PROPOSED COMMERCAIL APPLICATION: Successful completion fo the research would open the way in Phase II and beyond to meet two important commercial needs of peptide and protein separations. First, use of a novel separations to be dramatically improved through a reduced number of process steps, higher selectivities, and stronger binding. Second, selective recognition of protonated amie and carboxyl groups would greatly expand the number of peptides and proteins that could be effectively separated.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

7 SBIR/STTR records share this UEI (1988–2017). Reported award amounts total $686,287. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Environmental Protection Agency, National Science Foundation, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.